Dr. Christoph Esslinger

CSO, Board Member

• Founder of Memo Therapeutics AG

 

• Former CTO at CT Atlantic and Director of Antibody Technology at Neurimmune where he co-invented Aducanumab

 

• PhD in Cancer Immunology